Alpha Tau Medical (NASDAQ:DRTS) Lowered to "Sell" at Zacks Investment Research
Alpha Tau Medical (NASDAQ:DRTS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for […]